Ocular graft-versus-host disease: Experience, incidence, and treatment outcomes at a university-based tertiary care ophthalmology center
Authors:
Open Access
- 11 April 2025
- journal article
- Published by Elsevier in The Ocular Surface
- Vol. 37, 219-226
Abstract
No abstract availableKeywords
Funding Information
- National Eye Institute
- Research to Prevent Blindness
- National Institutes of Health (R24EY032440, R01EY024966, P30EY001792)
This publication has 22 references indexed in Scilit:
- Combinatorial therapy with immunosuppressive, immunomodulatory and tear substitute eyedrops (“Triple Play”) in Recalcitrant Immunological Ocular Surface DiseasesThe Ocular Surface, 2022
- Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of LifeTransplantation and Cellular Therapy, 2019
- Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factorsBone Marrow Transplantation, 2019
- Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTBone Marrow Transplantation, 2018
- Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host DiseaseAmerican Journal of Ophthalmology, 2018
- Impact of Ocular Chronic Graft-versus-Host Disease on Quality of LifeTransplantation and Cellular Therapy, 2015
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2015
- Combination of Rituximab and Intravenous Immunoglobulin for Recalcitrant Ocular Cicatricial PemphigoidOphthalmology, 2010
- Pulse IV cyclophosphamide in ocular inflammatory diseaseOphthalmology, 2004
- Clinical Significance of Reported Changes in Pain Severity☆☆☆★Annals of Emergency Medicine, 1996